Clinical Trials in San Antonio

Showing 2321-2340 of 7,028 trials

Enhancing Prolonged Exposure With Cannabidiol to Treat Posttraumatic Stress Disorder

NCT05132699

The primary goal of this pilot project is to demonstrate the safety and feasibility of using Cannabidiol (CBD) in combination with standard of care prolonged exposure (PE) psychotherapy to reduce PTSD symptoms.

Posttraumatic Stress DisorderStress Disorders, Post-Traumatic

The University of Texas Health Science Center at San Antonio21 participantsStarted Apr 2022

San Antonio, Texas, United States

COMPLETEDPhase 3< 1 mile

Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis

NCT04773587

This is a parallel group, double blind, vehicle-controlled study to assess the safety and efficacy of roflumilast (ARQ-151) cream vs vehicle applied once daily (qd) for 4 weeks by participants with atopic dermatitis (eczema).

Atopic Dermatitis Eczema

Arcutis Biotherapeutics, Inc.654 participantsStarted Jan 2021

Montgomery, Alabama, United States • Scottsdale, Arizona, United States • Little Rock, Arkansas, United States +46 more locations

Enhancing Prolonged Exposure With Cannabidiol to Treat Posttraumatic Stress Disorder

Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis

Find Trials by Condition in San Antonio

Open- Label Trial of Sipuleucel-T Administered to Active Surveillance Patients for Newly Diagnosed Prostate Cancer

Observational Study of Obstructive Lung Disease (NOVELTY)

Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies

A Study to Learn About The Study Medicine (PF-07038124) In Patients With Mild To Moderate Atopic Dermatitis Or Mild To Severe Plaque Psoriasis.

Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT141 in Patients With Unresectable or Metastatic CLDN18.2-positive Gastric, Pancreatic, Ovarian and Biliary Tract Tumors

Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment

Post-Market Study to Assess Outcomes of Patients Treated With AFX System Compared to Other EVAR Devices

Pilot Study of Brief Intervention to Support Diabetes Health-Related Quality of Life

Wearable Assessments in the Clinic and Home in PD

Safety and Anti-Tumor Activity of TYRA-200 in Advanced Cholangiocarcinoma With Activating FGFR2 Gene Alterations

Inhaled Imatinib Pulmonary Arterial Hypertension Clinical Trial - Follow Up Long Term Extension (IMPAHCT-FUL)

Study of LAU-7b in the Treatment of Cystic Fibrosis in Adults

Safety, Tolerability, and Pharmacokinetics Study of MK-8189 in Participants With Schizophrenia and Healthy Participants (MK-8189-011)

WHOOP ECG Software Performance Assessment Study

Ravulizumab in Thrombotic Microangiopathy Associated With a Trigger

A Study of LY3002813 in Participants With Memory Damage Due to Alzheimer's Disease (AD) or AD

A Study Evaluating the Effect of Filgotinib Dose De-escalation in Participants With Ulcerative Colitis (UC) in Remission

Use of Autologous Stem/Stromal Cells In Chronic Lung Disorders: Obstructive (COPD) & Restrictive (RLD)